tradingkey.logo

IDEXX rises after beating quarterly revenue estimates

ReutersFeb 2, 2026 1:06 PM

Shares of animal diagnostics maker IDEXX Laboratories IDXX.O rise 1.13% to $678.02 premarket

Co reports Q4 adj. profit of $3.08/shr vs analysts' average estimate of $2.93/shr - LSEG data

Brokerage Leerink Partners said non‑wellness vet visits, which drive most recurring diagnostics revenue, held up better than overall visit volumes in Q4

Co's quarterly revenue of $1.091 billion beats analysts' average expectation of $1.073 billion

Shares were up ~64% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI